These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26582418)

  • 1. How to model temporal changes in comorbidity for cancer patients using prospective cohort data.
    Lindhagen L; Van Hemelrijck M; Robinson D; Stattin P; Garmo H
    BMC Med Inform Decis Mak; 2015 Nov; 15():96. PubMed ID: 26582418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to measure temporal changes in care pathways for chronic diseases using health care registry data.
    Ventimiglia E; Van Hemelrijck M; Lindhagen L; Stattin P; Garmo H
    BMC Med Inform Decis Mak; 2019 May; 19(1):103. PubMed ID: 31146754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
    Beckmann K; Garmo H; Adolfsson J; Bosco C; Johansson E; Robinson D; Holmberg L; Stattin P; Van Hemelrijck M
    Eur Urol; 2019 Apr; 75(4):676-683. PubMed ID: 30497883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy.
    Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
    Yonsei Med J; 2014 Mar; 55(2):316-23. PubMed ID: 24532498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.
    Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
    Ann Surg Oncol; 2014 Feb; 21(2):677-83. PubMed ID: 24145996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males.
    Van Hemelrijck M; Ventimiglia E; Robinson D; Gedeborg R; Holmberg L; Stattin P; Garmo H
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):35. PubMed ID: 35135530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
    Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
    Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mortality after radical prostatectomy by Charlson comorbidity index.
    Guzzo TJ; Dluzniewski P; Orosco R; Platz EA; Partin AW; Han M
    Urology; 2010 Sep; 76(3):553-7. PubMed ID: 20627284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study.
    Westerberg M; Irenaeus S; Garmo H; Stattin P; Gedeborg R
    PLoS One; 2024; 19(1):e0296804. PubMed ID: 38236934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbidities at diagnosis on prostate cancer treatment and survival.
    Matthes KL; Limam M; Pestoni G; Held L; Korol D; Rohrmann S
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):707-715. PubMed ID: 29417258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies.
    Hall RE; Porter J; Quan H; Reeves MJ
    BMC Health Serv Res; 2019 Dec; 19(1):930. PubMed ID: 31796024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of the Modified Charlson Comorbidity Index in Incident Peritoneal Dialysis Patients: A National Population-Based Approach.
    Cho H; Kim MH; Kim HJ; Park JY; Ryu DR; Lee H; Lee JP; Lim CS; Kim KH; Oh KH; Joo KW; Kim YS; Kim DK
    Perit Dial Int; 2017 1-2; 37(1):94-102. PubMed ID: 27605681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study.
    Rajan P; Sooriakumaran P; Nyberg T; Akre O; Carlsson S; Egevad L; Steineck G; Wiklund NP
    J Clin Oncol; 2017 Nov; 35(31):3566-3574. PubMed ID: 28930493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
    Rider JR; Sandin F; Andrén O; Wiklund P; Hugosson J; Stattin P
    Eur Urol; 2013 Jan; 63(1):88-96. PubMed ID: 22902040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
    Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
    Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Charlson Index Is Insufficient to Control for Comorbidities in a National Trauma Registry.
    Renson A; Bjurlin MA
    J Surg Res; 2019 Apr; 236():319-325. PubMed ID: 30694772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study.
    Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC
    PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.